Navigation Links
Novo Nordisk and BGI establish global collaboration framework

March 2, 2012, Copenhagen, Denmark and Shenzhen, China Novo Nordisk, one of the world's leading companies in diabetes care and BGI, the world's largest genomics organization jointly announced that they have reached an agreement to establish a global collaboration framework, which provides an unprecedented collaborative opportunity for Novo Nordisk and BGI to accelerate their growth, execute their global partnering strategy and support disease research and development efforts. The agreement was signed by Professor Allan Ertmann Karlsen, Corporate and Scientific Vice President of Novo Nordisk and Dr. Ning Li, Director of BGI Europe.

Under the agreement, this collaboration will combine BGI's next generation sequencing platforms and bioinformatics capabilities with Novo Nordisk's expertise and experience in drug development under a global framework. This agreement is enforceable to Novo Nordisk's headquarter in Denmark, international production facilities in seven countries, and its affiliates or regional offices in 75 countries as well as BGI's headquarter in Shenzhen and affiliates worldwide, including BGI-Hong Kong, BGI-Europe, BGI-Americas, among others.

"We appreciate this great opportunity to bring our extensive genomics experience in the collaboration with Novo Nordisk." said Dr. Li, "With the recent opening of our first European Genome Centre in Denmark, we believe it will provide an excellent platform for us and our collaborators, and we are looking forward to establish more collaborations with more partners across Europe and worldwide. "


Contact: Jia Liu
BGI Shenzhen

Page: 1

Related biology news :

1. TET Systems and Novo Nordisk sign license agreement
2. NTU to establish Singapore as Asian hub in complexity science research
3. DFG to establish 4 new research units
4. Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology
5. Study establishes importance of tracking diseases associated with illegal wildlife trade
6. Rices Grande-Allen wins AHA Established Investigator Award
7. Malaysian Oil Palm Biomass Center established
8. Iowa State engineers establish national panel to advance a carbon negative economy
9. San Diego Zoo scientists establish cell cultures of endangered frog
10. UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento
11. DFG establishes 12 new research units
Post Your Comments:
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology: